Biophotonics Market By End User (Medical Diagnostics, Medical Therapeutic, Tests & Components, and Nonmedical Application) and Application (See-through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy, Analytical Sensing, and Biosensors): Global Opportunity Analysis and Industry Forecast, 2021–2030
Biophotonics is the science of generating and harnessing light to image, detect and manipulate biological materials. Biophotonics uses light and other forms of radiant energy to understand the inner workings of cells and tissues in living organisms. In biology, biophotonics is utilized to probe for molecular mechanisms, functions and structures. In medicine, it is used to study light-tissue interaction mechanisms at the micro/nano and macro organism level to detect, diagnose and treat diseases. Biophotonics helps in emission, detection, absorption, reflection, modification, and creation of radiation from bimolecular, cells, tissues, organisms and biomaterials.
The biophotonics market is expected to register substantial growth in the near future, attributed to emergence of nanotechnology. Moreover, increasing technological advancement and R&D activity in optical technologies across telecom & information technology sectors are the drivers of biophotonics market. However, factors like high price concern of biophotonics and complexity associated with biophotonics technology are the restraints of biophotonics market. The use of biophotonics in non-medical sectors is the opportunity for the biophotonics market.
Key market player included in this report are Affymetrix Inc., Andor Technology Ltd., Carl Zeiss AG, Becton Dickinson and Company, FEI Company, Hamamatsu Photonics K.K., Lumenis Ltd., Olympus Corporation, PerkinElmer Inc., and Zecotek Photonics Inc.
Key benefits for stakeholders
This report provides an extensive analysis of the current and emerging market trends and dynamics in the world biophotonics market.
Competitive intelligence (of leading manufacturers and distributors of biophotonics) helps in understanding the competitive scenario across the geographies.
This report entails the detailed quantitative analysis of the current market and estimations through 2020-2030, which assists in identifying the prevailing market opportunities.
Recent developments, key manufacturers, their market shares, and upcoming products have been listed.
Exhaustive analysis of the world biophotonics market by type, which helps in clear understanding market trends.
Comprehensive analysis of all regions is provided that determines the prevailing opportunities in these geographies.
The report provides micro level analysis for various segments based on Applications, end-user and geography, which brings a crystal clear picture of the market.
Market Segmentation
By End User
Medical Diagnostics
Medical Therapeutic
Tests & Components
Nonmedical Application
By Application
See-through Imaging
Inside Imaging
Spectro Molecular
Surface Imaging
Microscopy
Light Therapy
Analytical Sensing
Biosensors
By Region
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Rest of Europe
Asia-Pacific
China
India
Japan
South Korea
Australia
Rest of Asia-Pacific
LAMEA
Latin America
Middle East
Africa
- CHAPTER 1:INTRODUCTION
- 1.1.Report Description
- 1.2.Key Market Segments
- 1.3.Key Benefits
- 1.4.Research Methodology
- 1.4.1.Primary Research
- 1.4.2.Secondary Research
- 1.4.3.Analyst Tools and Models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.CXO Perspective
- CHAPTER 3:MARKET LANDSCAPE
- 3.1.Market Definition and Scope
- 3.2.Key Findings
- 3.2.1.Top Investment Pockets
- 3.2.2.Top Winning Strategies
- 3.3.Porter's Five Forces Analysis
- 3.3.1.Bargaining Power of Suppliers
- 3.3.2.Threat of New Entrants
- 3.3.3.Threat of Substitutes
- 3.3.4.Competitive Rivalry
- 3.3.5.Bargaining Power among Buyers
- 3.4.Market Share Analysis/Top Player Positioning
- 3.4.1.Market Share Analysis/Top Player Positioning 2020
- 3.5.Market Dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis
- CHAPTER 4:BIOPHOTONICS MARKET, BY END USER
- 4.1.Market Overview
- 4.1.1Market Size and Forecast, By End User
- 4.2.Medical Diagnostics
- 4.2.1.Key Market Trends, Growth Factors and Opportunities
- 4.2.2.Market Size and Forecast, By Region
- 4.2.3.Market Share Analysis, By Country
- 4.3.Medical Therapeutic
- 4.3.1.Key Market Trends, Growth Factors and Opportunities
- 4.3.2.Market Size and Forecast, By Region
- 4.3.3.Market Share Analysis, By Country
- 4.4.Test And Components
- 4.4.1.Key Market Trends, Growth Factors and Opportunities
- 4.4.2.Market Size and Forecast, By Region
- 4.4.3.Market Share Analysis, By Country
- 4.5.Non Medical Applications
- 4.5.1.Key Market Trends, Growth Factors and Opportunities
- 4.5.2.Market Size and Forecast, By Region
- 4.5.3.Market Share Analysis, By Country
- CHAPTER 5:BIOPHOTONICS MARKET, BY APPLICATIONS
- 5.1.Market Overview
- 5.1.1Market Size and Forecast, By Applications
- 5.2.See Through Imaging
- 5.2.1.Key Market Trends, Growth Factors and Opportunities
- 5.2.2.Market Size and Forecast, By Region
- 5.2.3.Market Share Analysis, By Country
- 5.3.Inside Imaging
- 5.3.1.Key Market Trends, Growth Factors and Opportunities
- 5.3.2.Market Size and Forecast, By Region
- 5.3.3.Market Share Analysis, By Country
- 5.4.Spectro Molecular
- 5.4.1.Key Market Trends, Growth Factors and Opportunities
- 5.4.2.Market Size and Forecast, By Region
- 5.4.3.Market Share Analysis, By Country
- 5.5.Surface Imaging
- 5.5.1.Key Market Trends, Growth Factors and Opportunities
- 5.5.2.Market Size and Forecast, By Region
- 5.5.3.Market Share Analysis, By Country
- 5.6.Microscopy
- 5.6.1.Key Market Trends, Growth Factors and Opportunities
- 5.6.2.Market Size and Forecast, By Region
- 5.6.3.Market Share Analysis, By Country
- 5.7.Light Therapy
- 5.7.1.Key Market Trends, Growth Factors and Opportunities
- 5.7.2.Market Size and Forecast, By Region
- 5.7.3.Market Share Analysis, By Country
- 5.8.Analytical Sensing
- 5.8.1.Key Market Trends, Growth Factors and Opportunities
- 5.8.2.Market Size and Forecast, By Region
- 5.8.3.Market Share Analysis, By Country
- 5.9.Biosensors
- 5.9.1.Key Market Trends, Growth Factors and Opportunities
- 5.9.2.Market Size and Forecast, By Region
- 5.9.3.Market Share Analysis, By Country
- CHAPTER 6:BIOPHOTONICS MARKET, BY REGION
- 6.1.Market Overview
- 6.1.1Market Size and Forecast, By Region
- 6.2.North America
- 6.2.1.Key Market Trends and Opportunities
- 6.2.2.Market Size and Forecast, By End User
- 6.2.3.Market Size and Forecast, By Applications
- 6.2.4.Market Size and Forecast, By Country
- 6.2.5.U.s. Biophotonics Market
- 6.2.5.1.Market Size and Forecast, By End User
- 6.2.5.2.Market Size and Forecast, By Applications
- 6.2.6.Canada Biophotonics Market
- 6.2.6.1.Market Size and Forecast, By End User
- 6.2.6.2.Market Size and Forecast, By Applications
- 6.2.7.Mexico Biophotonics Market
- 6.2.7.1.Market Size and Forecast, By End User
- 6.2.7.2.Market Size and Forecast, By Applications
- 6.3.Europe
- 6.3.1.Key Market Trends and Opportunities
- 6.3.2.Market Size and Forecast, By End User
- 6.3.3.Market Size and Forecast, By Applications
- 6.3.4.Market Size and Forecast, By Country
- 6.3.5.Uk Biophotonics Market
- 6.3.5.1.Market Size and Forecast, By End User
- 6.3.5.2.Market Size and Forecast, By Applications
- 6.3.6.Germany Biophotonics Market
- 6.3.6.1.Market Size and Forecast, By End User
- 6.3.6.2.Market Size and Forecast, By Applications
- 6.3.7.France Biophotonics Market
- 6.3.7.1.Market Size and Forecast, By End User
- 6.3.7.2.Market Size and Forecast, By Applications
- 6.3.8.Italy Biophotonics Market
- 6.3.8.1.Market Size and Forecast, By End User
- 6.3.8.2.Market Size and Forecast, By Applications
- 6.3.9.Rest Of Europe Biophotonics Market
- 6.3.9.1.Market Size and Forecast, By End User
- 6.3.9.2.Market Size and Forecast, By Applications
- 6.4.Asia-Pacific
- 6.4.1.Key Market Trends and Opportunities
- 6.4.2.Market Size and Forecast, By End User
- 6.4.3.Market Size and Forecast, By Applications
- 6.4.4.Market Size and Forecast, By Country
- 6.4.5.China Biophotonics Market
- 6.4.5.1.Market Size and Forecast, By End User
- 6.4.5.2.Market Size and Forecast, By Applications
- 6.4.6.Japan Biophotonics Market
- 6.4.6.1.Market Size and Forecast, By End User
- 6.4.6.2.Market Size and Forecast, By Applications
- 6.4.7.India Biophotonics Market
- 6.4.7.1.Market Size and Forecast, By End User
- 6.4.7.2.Market Size and Forecast, By Applications
- 6.4.8.South Korea Biophotonics Market
- 6.4.8.1.Market Size and Forecast, By End User
- 6.4.8.2.Market Size and Forecast, By Applications
- 6.4.9.Australia Biophotonics Market
- 6.4.9.1.Market Size and Forecast, By End User
- 6.4.9.2.Market Size and Forecast, By Applications
- 6.4.10.Rest of Asia Pacific Biophotonics Market
- 6.4.10.1.Market Size and Forecast, By End User
- 6.4.10.2.Market Size and Forecast, By Applications
- 6.5.LAMEA
- 6.5.1.Key Market Trends and Opportunities
- 6.5.2.Market Size and Forecast, By End User
- 6.5.3.Market Size and Forecast, By Applications
- 6.5.4.Market Size and Forecast, By Country
- 6.5.5.Latin America Biophotonics Market
- 6.5.5.1.Market Size and Forecast, By End User
- 6.5.5.2.Market Size and Forecast, By Applications
- 6.5.6.Middle East Biophotonics Market
- 6.5.6.1.Market Size and Forecast, By End User
- 6.5.6.2.Market Size and Forecast, By Applications
- 6.5.7.Africa Biophotonics Market
- 6.5.7.1.Market Size and Forecast, By End User
- 6.5.7.2.Market Size and Forecast, By Applications
- CHAPTER 7:COMPANY PROFILES
- 7.1.Thermo Fisher Scientific Inc
- 7.1.1.Company Overview
- 7.1.2.Key Executives
- 7.1.3.Company snapshot
- 7.1.4.Operating business segments
- 7.1.5.Product portfolio
- 7.1.6.Business Performance
- 7.1.7.Key Strategic Moves and Developments
- 7.2.Oxford Technologies
- 7.2.1.Company Overview
- 7.2.2.Key Executives
- 7.2.3.Company snapshot
- 7.2.4.Operating business segments
- 7.2.5.Product portfolio
- 7.2.6.Business Performance
- 7.2.7.Key Strategic Moves and Developments
- 7.3.Carl Zeiss AG
- 7.3.1.Company Overview
- 7.3.2.Key Executives
- 7.3.3.Company snapshot
- 7.3.4.Operating business segments
- 7.3.5.Product portfolio
- 7.3.6.Business Performance
- 7.3.7.Key Strategic Moves and Developments
- 7.4.Becton Dickinson And Company
- 7.4.1.Company Overview
- 7.4.2.Key Executives
- 7.4.3.Company snapshot
- 7.4.4.Operating business segments
- 7.4.5.Product portfolio
- 7.4.6.Business Performance
- 7.4.7.Key Strategic Moves and Developments
- 7.5.Glenbrook Technologies Inc
- 7.5.1.Company Overview
- 7.5.2.Key Executives
- 7.5.3.Company snapshot
- 7.5.4.Operating business segments
- 7.5.5.Product portfolio
- 7.5.6.Business Performance
- 7.5.7.Key Strategic Moves and Developments
- 7.6.Hamamatsu Photonics
- 7.6.1.Company Overview
- 7.6.2.Key Executives
- 7.6.3.Company snapshot
- 7.6.4.Operating business segments
- 7.6.5.Product portfolio
- 7.6.6.Business Performance
- 7.6.7.Key Strategic Moves and Developments
- 7.7.Lumenis Ltd
- 7.7.1.Company Overview
- 7.7.2.Key Executives
- 7.7.3.Company snapshot
- 7.7.4.Operating business segments
- 7.7.5.Product portfolio
- 7.7.6.Business Performance
- 7.7.7.Key Strategic Moves and Developments
- 7.8.Olympus Corporation
- 7.8.1.Company Overview
- 7.8.2.Key Executives
- 7.8.3.Company snapshot
- 7.8.4.Operating business segments
- 7.8.5.Product portfolio
- 7.8.6.Business Performance
- 7.8.7.Key Strategic Moves and Developments
- 7.9.PerkinElmer Inc
- 7.9.1.Company Overview
- 7.9.2.Key Executives
- 7.9.3.Company snapshot
- 7.9.4.Operating business segments
- 7.9.5.Product portfolio
- 7.9.6.Business Performance
- 7.9.7.Key Strategic Moves and Developments
- 7.10.Zenalux Biomedical Inc
- 7.10.1.Company Overview
- 7.10.2.Key Executives
- 7.10.3.Company snapshot
- 7.10.4.Operating business segments
- 7.10.5.Product portfolio
- 7.10.6.Business Performance
- 7.10.7.Key Strategic Moves and Developments
- Note: *Details on financial performance and strategic moves and developments may not be captured for unlisted companies.
- *List of companies profiled in this TOC is tentative and may change after detailed analysis.
- *Market size and forecast will be provided from 2020-2030, and forecast period would be 2021-2030.
- *The provided information and segments are for representation purpose only. The actual information delivered would change significantly as per findings during the course of study and upon its completion.
- LIST OF TABLES
- TABLE 1.GLOBAL BIOPHOTONICS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 2.GLOBAL BIOPHOTONICS MARKET FOR MEDICAL DIAGNOSTICS, BY REGION, 2020-2030 ($MILLION)
- TABLE 3.GLOBAL BIOPHOTONICS MARKET FOR MEDICAL THERAPEUTIC, BY REGION, 2020-2030 ($MILLION)
- TABLE 4.GLOBAL BIOPHOTONICS MARKET FOR TEST AND COMPONENTS, BY REGION, 2020-2030 ($MILLION)
- TABLE 5.GLOBAL BIOPHOTONICS MARKET FOR NON MEDICAL APPLICATIONS, BY REGION, 2020-2030 ($MILLION)
- TABLE 6.GLOBAL BIOPHOTONICS MARKET, BY APPLICATIONS, 2020-2030 ($MILLION)
- TABLE 7.GLOBAL BIOPHOTONICS MARKET FOR SEE THROUGH IMAGING, BY REGION, 2020-2030 ($MILLION)
- TABLE 8.GLOBAL BIOPHOTONICS MARKET FOR INSIDE IMAGING, BY REGION, 2020-2030 ($MILLION)
- TABLE 9.GLOBAL BIOPHOTONICS MARKET FOR SPECTRO MOLECULAR, BY REGION, 2020-2030 ($MILLION)
- TABLE 10.GLOBAL BIOPHOTONICS MARKET FOR SURFACE IMAGING, BY REGION, 2020-2030 ($MILLION)
- TABLE 11.GLOBAL BIOPHOTONICS MARKET FOR MICROSCOPY, BY REGION, 2020-2030 ($MILLION)
- TABLE 12.GLOBAL BIOPHOTONICS MARKET FOR LIGHT THERAPY, BY REGION, 2020-2030 ($MILLION)
- TABLE 13.GLOBAL BIOPHOTONICS MARKET FOR ANALYTICAL SENSING, BY REGION, 2020-2030 ($MILLION)
- TABLE 14.GLOBAL BIOPHOTONICS MARKET FOR BIOSENSORS, BY REGION, 2020-2030 ($MILLION)
- TABLE 15.GLOBAL BIOPHOTONICS MARKET, BY REGION, 2020-2030 ($MILLION)
- TABLE 16.NORTH AMERICA BIOPHOTONICS, BY END USER, 2020-2030 ($MILLION)
- TABLE 17.NORTH AMERICA BIOPHOTONICS, BY APPLICATIONS, 2020-2030 ($MILLION)
- TABLE 18.U.S. BIOPHOTONICS, BY END USER, 2020-2030 ($MILLION)
- TABLE 19.U.S. BIOPHOTONICS, BY APPLICATIONS, 2020-2030 ($MILLION)
- TABLE 20.CANADA BIOPHOTONICS, BY END USER, 2020-2030 ($MILLION)
- TABLE 21.CANADA BIOPHOTONICS, BY APPLICATIONS, 2020-2030 ($MILLION)
- TABLE 22.MEXICO BIOPHOTONICS, BY END USER, 2020-2030 ($MILLION)
- TABLE 23.MEXICO BIOPHOTONICS, BY APPLICATIONS, 2020-2030 ($MILLION)
- TABLE 24.EUROPE BIOPHOTONICS, BY END USER, 2020-2030 ($MILLION)
- TABLE 25.EUROPE BIOPHOTONICS, BY APPLICATIONS, 2020-2030 ($MILLION)
- TABLE 26.UK BIOPHOTONICS, BY END USER, 2020-2030 ($MILLION)
- TABLE 27.UK BIOPHOTONICS, BY APPLICATIONS, 2020-2030 ($MILLION)
- TABLE 28.GERMANY BIOPHOTONICS, BY END USER, 2020-2030 ($MILLION)
- TABLE 29.GERMANY BIOPHOTONICS, BY APPLICATIONS, 2020-2030 ($MILLION)
- TABLE 30.FRANCE BIOPHOTONICS, BY END USER, 2020-2030 ($MILLION)
- TABLE 31.FRANCE BIOPHOTONICS, BY APPLICATIONS, 2020-2030 ($MILLION)
- TABLE 32.ITALY BIOPHOTONICS, BY END USER, 2020-2030 ($MILLION)
- TABLE 33.ITALY BIOPHOTONICS, BY APPLICATIONS, 2020-2030 ($MILLION)
- TABLE 34.REST OF EUROPE BIOPHOTONICS, BY END USER, 2020-2030 ($MILLION)
- TABLE 35.REST OF EUROPE BIOPHOTONICS, BY APPLICATIONS, 2020-2030 ($MILLION)
- TABLE 36.ASIA-PACIFIC BIOPHOTONICS, BY END USER, 2020-2030 ($MILLION)
- TABLE 37.ASIA-PACIFIC BIOPHOTONICS, BY APPLICATIONS, 2020-2030 ($MILLION)
- TABLE 38.CHINA BIOPHOTONICS, BY END USER, 2020-2030 ($MILLION)
- TABLE 39.CHINA BIOPHOTONICS, BY APPLICATIONS, 2020-2030 ($MILLION)
- TABLE 40.JAPAN BIOPHOTONICS, BY END USER, 2020-2030 ($MILLION)
- TABLE 41.JAPAN BIOPHOTONICS, BY APPLICATIONS, 2020-2030 ($MILLION)
- TABLE 42.INDIA BIOPHOTONICS, BY END USER, 2020-2030 ($MILLION)
- TABLE 43.INDIA BIOPHOTONICS, BY APPLICATIONS, 2020-2030 ($MILLION)
- TABLE 44.SOUTH KOREA BIOPHOTONICS, BY END USER, 2020-2030 ($MILLION)
- TABLE 45.SOUTH KOREA BIOPHOTONICS, BY APPLICATIONS, 2020-2030 ($MILLION)
- TABLE 46.AUSTRALIA BIOPHOTONICS, BY END USER, 2020-2030 ($MILLION)
- TABLE 47.AUSTRALIA BIOPHOTONICS, BY APPLICATIONS, 2020-2030 ($MILLION)
- TABLE 48.REST OF ASIA PACIFIC BIOPHOTONICS, BY END USER, 2020-2030 ($MILLION)
- TABLE 49.REST OF ASIA PACIFIC BIOPHOTONICS, BY APPLICATIONS, 2020-2030 ($MILLION)
- TABLE 50.LAMEA BIOPHOTONICS, BY END USER, 2020-2030 ($MILLION)
- TABLE 51.LAMEA BIOPHOTONICS, BY APPLICATIONS, 2020-2030 ($MILLION)
- TABLE 52.LATIN AMERICA BIOPHOTONICS, BY END USER, 2020-2030 ($MILLION)
- TABLE 53.LATIN AMERICA BIOPHOTONICS, BY APPLICATIONS, 2020-2030 ($MILLION)
- TABLE 54.MIDDLE EAST BIOPHOTONICS, BY END USER, 2020-2030 ($MILLION)
- TABLE 55.MIDDLE EAST BIOPHOTONICS, BY APPLICATIONS, 2020-2030 ($MILLION)
- TABLE 56.AFRICA BIOPHOTONICS, BY END USER, 2020-2030 ($MILLION)
- TABLE 57.AFRICA BIOPHOTONICS, BY APPLICATIONS, 2020-2030 ($MILLION)
- TABLE 58.THERMO FISHER SCIENTIFIC INC: KEY EXECUTIVES
- TABLE 59.THERMO FISHER SCIENTIFIC INC: COMPANY SNAPSHOT
- TABLE 60.THERMO FISHER SCIENTIFIC INC: OPERATING SEGMENTS
- TABLE 61.THERMO FISHER SCIENTIFIC INC: PRODUCT PORTFOLIO
- TABLE 62.THERMO FISHER SCIENTIFIC INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 63.OXFORD TECHNOLOGIES: KEY EXECUTIVES
- TABLE 64.OXFORD TECHNOLOGIES: COMPANY SNAPSHOT
- TABLE 65.OXFORD TECHNOLOGIES: OPERATING SEGMENTS
- TABLE 66.OXFORD TECHNOLOGIES: PRODUCT PORTFOLIO
- TABLE 67.OXFORD TECHNOLOGIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 68.CARL ZEISS AG: KEY EXECUTIVES
- TABLE 69.CARL ZEISS AG: COMPANY SNAPSHOT
- TABLE 70.CARL ZEISS AG: OPERATING SEGMENTS
- TABLE 71.CARL ZEISS AG: PRODUCT PORTFOLIO
- TABLE 72.CARL ZEISS AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 73.BECTON DICKINSON AND COMPANY: KEY EXECUTIVES
- TABLE 74.BECTON DICKINSON AND COMPANY: COMPANY SNAPSHOT
- TABLE 75.BECTON DICKINSON AND COMPANY: OPERATING SEGMENTS
- TABLE 76.BECTON DICKINSON AND COMPANY: PRODUCT PORTFOLIO
- TABLE 77.BECTON DICKINSON AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 78.GLENBROOK TECHNOLOGIES INC: KEY EXECUTIVES
- TABLE 79.GLENBROOK TECHNOLOGIES INC: COMPANY SNAPSHOT
- TABLE 80.GLENBROOK TECHNOLOGIES INC: OPERATING SEGMENTS
- TABLE 81.GLENBROOK TECHNOLOGIES INC: PRODUCT PORTFOLIO
- TABLE 82.GLENBROOK TECHNOLOGIES INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 83.HAMAMATSU PHOTONICS: KEY EXECUTIVES
- TABLE 84.HAMAMATSU PHOTONICS: COMPANY SNAPSHOT
- TABLE 85.HAMAMATSU PHOTONICS: OPERATING SEGMENTS
- TABLE 86.HAMAMATSU PHOTONICS: PRODUCT PORTFOLIO
- TABLE 87.HAMAMATSU PHOTONICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 88.LUMENIS LTD: KEY EXECUTIVES
- TABLE 89.LUMENIS LTD: COMPANY SNAPSHOT
- TABLE 90.LUMENIS LTD: OPERATING SEGMENTS
- TABLE 91.LUMENIS LTD: PRODUCT PORTFOLIO
- TABLE 92.LUMENIS LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 93.OLYMPUS CORPORATION: KEY EXECUTIVES
- TABLE 94.OLYMPUS CORPORATION: COMPANY SNAPSHOT
- TABLE 95.OLYMPUS CORPORATION: OPERATING SEGMENTS
- TABLE 96.OLYMPUS CORPORATION: PRODUCT PORTFOLIO
- TABLE 97.OLYMPUS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 98.PERKINELMER INC: KEY EXECUTIVES
- TABLE 99.PERKINELMER INC: COMPANY SNAPSHOT
- TABLE 100.PERKINELMER INC: OPERATING SEGMENTS
- TABLE 101.PERKINELMER INC: PRODUCT PORTFOLIO
- TABLE 102.PERKINELMER INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 103.ZENALUX BIOMEDICAL INC: KEY EXECUTIVES
- TABLE 104.ZENALUX BIOMEDICAL INC: COMPANY SNAPSHOT
- TABLE 105.ZENALUX BIOMEDICAL INC: OPERATING SEGMENTS
- TABLE 106.ZENALUX BIOMEDICAL INC: PRODUCT PORTFOLIO
- TABLE 107.ZENALUX BIOMEDICAL INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- LIST OF FIGURES
- FIGURE 1.GLOBAL BIOPHOTONICS MARKET SEGMENTATION
- FIGURE 2.GLOBAL BIOPHOTONICS MARKET
- FIGURE 3.SEGMENTATION BIOPHOTONICS MARKET
- FIGURE 4.TOP INVESTMENT POCKET IN BIOPHOTONICS MARKET
- FIGURE 5.TOP WINNING STRATEGIES, 2019-2021*
- FIGURE 6.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021(%)
- FIGURE 7.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021*
- FIGURE 8.MODERATE BARGAINING POWER OF BUYERS
- FIGURE 9.MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 10.MODERATE THREAT OF NEW ENTRANTS
- FIGURE 11.LOW THREAT OF SUBSTITUTION
- FIGURE 12.HIGH COMPETITIVE RIVALRY
- FIGURE 13.TOP PLAYER POSITIONING, 2020
- FIGURE 14.MARKET SHARE ANALYSIS, 2020
- FIGURE 15.RESTRAINTS AND DRIVERS: BIOPHOTONICS MARKET
- FIGURE 16.BIOPHOTONICS MARKET SEGMENTATION, BY END USER
- FIGURE 17.BIOPHOTONICS MARKET FOR MEDICAL DIAGNOSTICS, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 18.BIOPHOTONICS MARKET FOR MEDICAL THERAPEUTIC, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 19.BIOPHOTONICS MARKET FOR TEST AND COMPONENTS, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 20.BIOPHOTONICS MARKET FOR NON MEDICAL APPLICATIONS, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 21.BIOPHOTONICS MARKET SEGMENTATION, BY APPLICATIONS
- FIGURE 22.BIOPHOTONICS MARKET FOR SEE THROUGH IMAGING, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 23.BIOPHOTONICS MARKET FOR INSIDE IMAGING, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 24.BIOPHOTONICS MARKET FOR SPECTRO MOLECULAR, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 25.BIOPHOTONICS MARKET FOR SURFACE IMAGING, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 26.BIOPHOTONICS MARKET FOR MICROSCOPY, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 27.BIOPHOTONICS MARKET FOR LIGHT THERAPY, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 28.BIOPHOTONICS MARKET FOR ANALYTICAL SENSING, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 29.BIOPHOTONICS MARKET FOR BIOSENSORS, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 30.THERMO FISHER SCIENTIFIC INC: NET SALES, 2018-2020 ($MILLION)
- FIGURE 31.THERMO FISHER SCIENTIFIC INC: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 32.THERMO FISHER SCIENTIFIC INC: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 33.OXFORD TECHNOLOGIES: NET SALES, 2018-2020 ($MILLION)
- FIGURE 34.OXFORD TECHNOLOGIES: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 35.OXFORD TECHNOLOGIES: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 36.CARL ZEISS AG: NET SALES, 2018-2020 ($MILLION)
- FIGURE 37.CARL ZEISS AG: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 38.CARL ZEISS AG: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 39.BECTON DICKINSON AND COMPANY: NET SALES, 2018-2020 ($MILLION)
- FIGURE 40.BECTON DICKINSON AND COMPANY: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 41.BECTON DICKINSON AND COMPANY: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 42.GLENBROOK TECHNOLOGIES INC: NET SALES, 2018-2020 ($MILLION)
- FIGURE 43.GLENBROOK TECHNOLOGIES INC: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 44.GLENBROOK TECHNOLOGIES INC: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 45.HAMAMATSU PHOTONICS: NET SALES, 2018-2020 ($MILLION)
- FIGURE 46.HAMAMATSU PHOTONICS: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 47.HAMAMATSU PHOTONICS: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 48.LUMENIS LTD: NET SALES, 2018-2020 ($MILLION)
- FIGURE 49.LUMENIS LTD: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 50.LUMENIS LTD: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 51.OLYMPUS CORPORATION: NET SALES, 2018-2020 ($MILLION)
- FIGURE 52.OLYMPUS CORPORATION: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 53.OLYMPUS CORPORATION: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 54.PERKINELMER INC: NET SALES, 2018-2020 ($MILLION)
- FIGURE 55.PERKINELMER INC: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 56.PERKINELMER INC: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 57.ZENALUX BIOMEDICAL INC: NET SALES, 2018-2020 ($MILLION)
- FIGURE 58.ZENALUX BIOMEDICAL INC: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 59.ZENALUX BIOMEDICAL INC: REVENUE SHARE, BY REGION, 2020 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook